摘要
目的:研究分析阿司匹林联合氯吡格雷治疗急性缺血性脑血管病的临床治疗效果。方法:选择我院于2012年6月-2014年6月收治的急性缺血性脑血管病患者120例作为研究对象,按照随机分组法将其分为观察组和对照组两组,每组各60例。对照组单纯采用阿司匹林进行治疗,观察组在对照组的基础上加用氯吡格雷治疗。对比观察两组患者NIHSS评分、治疗效果、复发率以及不良反应发生率的情况。结果:治疗后两组患者的NIHSS评分显著优于治疗前,观察组患者在治疗后的NIHSS评分显著高于对照组,差异具有统计学意义(P<0.05)。观察组患者的治疗总有效率达到91.67%(55/60),显著高于对照组患者的66.67%(40/60),差异具有统计学意义(P<0.05)。观察组患者的复发率为5.00%(3/60),显著低于对照组的30.00%(18/60),差异具有统计学意义(P<0.05)。结论:对于急性缺血性脑血管病患者采用阿司匹林联合氯吡格雷治疗效果显著,且能够有效降低复发率,值得临床推广运用。
Objective： To research clinical effects of Aspirin plus Clopidogrel on acute ischemic cerebrovascular disease. Methods： 120 patients from June 2013 to June 2014 in our hospital were selected as research objects and divided into the observation group and the control group by randomization method, 60 cases for each. The control group was treated with Aspirin. The observation group was treated with Clopidogrel more. NIHSS scores, clinical efficacy, recurrence and incidence of adverse reactions in two groups were observed and compared. Results： After the treatment, NIHSS scores in two groups were both better than before; and the observation group was much higher than the control group; the difference was statistically significant. The total efficiency in the observation group was 91.67% （55/60）, higher than 66.67% （40/60） in the control group. The recurrence in the observation group was 5.00% （3/60）, significantly lower than 30.00% （18/60） in the control group （P〈0.05）. Conclusion： Treating acute ischemic cerebrovascular disease with Aspirin plus Clopidogrel showed significantly effective, could effectively reduce the recurrence, was worthy of promotion.
出处
《中医临床研究》
2015年第29期125-126,共2页
Clinical Journal Of Chinese Medicine
